63名員工變“合夥人” 鳳祥股份爲達成戰略目標鎖定核心團隊
格隆匯12月11日丨新消費品牌優形的母公司鳳祥股份(09977.HK)於12月10日發佈了股權激勵公告。這份公告披露,鳳祥股份擬在公開市場購買共計2609.76萬股的股份,並將其中2348.78萬股,授予63名獲選公司僱員;其中260.98萬股暫存入信託基金池,作爲日後授予獎勵的儲備。這也意味着,作爲我國首家在港股上市的雞肉消費公司,鳳祥股份已經確定了未來幾年的戰略發展目標,並正在謀求通過綁定核心團隊和關鍵人才,來保證未來的高增長態勢。值得關注的是,鳳祥股份此次計劃爲其未來吸納其他高級人才也留出了空間。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.